Breaking Stories

Coronavirus Update: Vir, GSK’s COVID-19 antibody treatment works against omicron in a lab study, and WHO no longer recommends convalescent plasma


Vir Biotechnology and GlaxoSmithKline’s COVID-19 antibody treatment worked against omicron in a laboratory study.

International Living: Everything you need to know about Medicare overseas — and why expats should enroll

Previous article

NewsWatch: A sales surge might make this industry your best stock market play for 2022

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *